How a Mutation in PDGF Receptor Affects Melanoma Growth
Author Information
Author(s): Suzuki Shioto, Carl-Henrik Heldin, Rainer Lothar Heuchel
Primary Institution: Ludwig Institute for Cancer Research, Uppsala Branch, Uppsala, Sweden
Hypothesis
Does the activating mutation D849N in PDGF receptor-β influence tumor establishment and growth in melanoma?
Conclusion
The activated PDGFR-β (D849N) in the host animal increased the total vessel area and the average vessel surface, resulting in a shorter lag phase during tumor establishment.
Supporting Evidence
- Activated PDGFR-β led to earlier tumor establishment in mice.
- Total vessel area and average vessel surface were higher in tumors from mutant mice.
- At later stages, tumor growth rates were similar between wild type and mutant mice.
Takeaway
A specific mutation in a protein that helps cells grow made tumors grow faster in mice by improving blood supply.
Methodology
B16 melanoma cells were injected into mice with the D849N mutation and tumor growth was measured and analyzed for vascular characteristics.
Potential Biases
Potential bias in the interpretation of results due to the specific mouse model used.
Limitations
The study primarily focused on early tumor establishment and did not explore long-term tumor behavior beyond a certain size.
Participant Demographics
Mice used were of the C57Bl/6 strain, including both wild type and D849N-mutant.
Statistical Information
P-Value
0.047
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website